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Abstract
Herpes simplex virus type 1 (HSV-1) infection results in lifelong chronic infection of trigeminal ganglion (TG) neurons, also
referred to as neuronal HSV-1 latency, with periodic reactivation leading to recrudescent herpetic disease in some persons.
HSV-1 proteins are expressed in a temporally coordinated fashion during lytic infection, but their expression pattern during
latent infection is largely unknown. Selective retention of HSV-1 reactive T-cells in human TG suggests their role in
controlling reactivation by recognizing locally expressed HSV-1 proteins. We characterized the HSV-1 proteins recognized by
virus-specific CD4 and CD8 T-cells recovered from human HSV-1–infected TG. T-cell clusters, consisting of both CD4 and
CD8 T-cells, surrounded neurons and expressed mRNAs and proteins consistent with in situ antigen recognition and antiviral
function. HSV-1 proteome-wide scans revealed that intra-TG T-cell responses included both CD4 and CD8 T-cells directed to
one to three HSV-1 proteins per person. HSV-1 protein ICP6 was targeted by CD8 T-cells in 4 of 8 HLA-discordant donors. In
situ tetramer staining demonstrated HSV-1-specific CD8 T-cells juxtaposed to TG neurons. Intra-TG retention of virus-specific
CD4 T-cells, validated to the HSV-1 peptide level, implies trafficking of viral proteins from neurons to HLA class II-expressing
non-neuronal cells for antigen presentation. The diversity of viral proteins targeted by TG T-cells across all kinetic and
functional classes of viral proteins suggests broad HSV-1 protein expression, and viral antigen processing and presentation,
in latently infected human TG. Collectively, the human TG represents an immunocompetent environment for both CD4 and
CD8 T-cell recognition of HSV-1 proteins expressed during latent infection. HSV-1 proteins recognized by TG-resident T-cells,
particularly ICP6 and VP16, are potential HSV-1 vaccine candidates.
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Introduction
The neurotropic human alphaherpesvirus herpes simplex virus
type 1 (HSV-1) is endemic worldwide. It is acquired during early
childhood via the orofacial route resulting in a lifelong chronic
infection of neurons, also referred to as neuronal HSV-1 latency,
in the bilateral trigeminal ganglia (TG) [1]. During latency no
infectious virus is produced, virus transcription is mainly directed
to latency-associated transcripts (LATs) and microRNAs, and
HSV-1 proteins are undetectable using standard methods [2–7].
Latent HSV-1 periodically reactivates, producing infectious virus
that may lead to recrudescent lesions in some persons. Both
primary and recurrent disease can result in clinical disorders of
variable severity or even death, emphasizing the unmet need for
preventive and therapeutic vaccines [1]. The candidate HSV
subunit vaccines, based on the HSV glycoproteins B (gB) and gD
were tested in human phase III trials, but were not effective [8–
10]. Vaccines induced antigen-specific antibodies and CD4 T-
cells, but not CD8 T-cells, arguing for novel vaccine formulations
that include specific HSV-1 antigens targeted by both antibodies
as well as CD4 and CD8 T-cells [11].
Studies in humans and HSV-1 mouse models suggest a pivotal
role for virus-specific CD8 T-cells in the control HSV-1
reactivation. Virus-specific CD8 T-cells, expressing an activated
effector memory T-cell phenotype, are selectively retained in
HSV-1–infected ganglia [5,12–15]. In the HSV-1 mouse model
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with a C57BL/6 background, the HSV-specific intra-TG CD8 T-
cells inhibit HSV-1 reactivation by secreting interferon-c (IFN-c)
and granzyme B (grB), and are mainly directed against an
immunodominant HSV-1 gB epitope [16–19]. In nature, howev-
er, HSV-1 only infects humans. Because HSV-1 infections in mice
mimic but are not equivalent to human disease, it is important that
findings from mouse models are confirmed and extended to
humans [20–22]. Moreover, the HSV-1 antigens recognized by
human TG-infiltrating T-cells are rational candidates for HSV-1
subunit vaccines.
HSV-1 encodes at least 77 proteins that during lytic infection
are sequentially expressed in a coordinated fashion as immediate
early (a), early (b), leaky late (c1) and true late proteins (c2) [1,23].
Expression of c2 proteins depends on viral DNA replication.
While infectious virions eventually assemble in distal axonal
structures after reactivation, the temporal expression and traffick-
ing of HSV-1 proteins in human neurons during latency is largely
unknown. We previously showed reactivity of human TG-derived
CD4 and CD8 T-cells to whole HSV-1 [15], but not which
proteins were susceptible to local immune recognition. The
detection of transcripts encoding the HSV-1 a proteins infecting
cell polypeptide 0 (ICP0) and ICP4 in human TG suggests that this
kinetic class of proteins is expressed during latency or early after
reactivation [5,7]. However, their accessibility to antigen process-
ing and presentation within TG-resident cells for local T-cell
surveillance is unclear. The aims of this study were to characterize
the functional properties and HSV-1 antigens recognized by T-
cells in HSV-1–infected human TG.
Results
Transcripts Levels of T-Cell Cytolytic Effector Molecules
and Cytokines Correlate with CD8b Transcript Levels and
HSV-1 DNA Load in Human TG
In contrast to the HSV-1 mouse models, human TG are
commonly co-infected with HSV-1 and the closely related
neurotropic human alphaherpesvirus varicella-zoster virus (VZV)
[13,15,20,24]. To gain insight into the functional properties of
human TG-residing T-cells in relation to latent HSV-1 and
VZV we determined the transcript levels of the T-cell cytolytic
effector molecules perforin and grB, and the cytokines IFN-c
and tumor necrosis factor-a (TNF-a) in 26 TG of 16 donors by
reverse transcriptase real-time PCR [25]. We first determined
the prevalence and viral load of latent HSV-1 and VZV by real-
time PCR. HSV-1 and VZV DNA was detectable in 17 (65%)
and 23 (89%) of the 26 TG analyzed, respectively. Sixteen TG
contained DNA of both viruses, seven TG had only VZV, one
TG had only HSV-1 and two TG had no detectable DNA of
either virus. The presence of virus-specific DNA correlated with
the donor’s HSV-1 and VZV serostatus and was commonly
detected in both TG of each individual (data not shown).
Consistent with previous reports, the mean number 6 standard
error of the mean (SEM) of HSV-1 genome equivalent copies
per 105 TG cells (1,8506427) was significantly higher compared
to VZV (6936184) (p=0.015) (Figure 1A) [15,24]. The intra-
TG HSV-1 and VZV DNA load did not correlate in paired
analysis (Figure 1B). Transcription of the CD8 T-cell–specific
gene CD8b correlated weakly with the intra-TG HSV-1
(p=0.005), but not the VZV DNA load (p=0.19) (Figure 1C).
Next, the expression levels of the T cell transcripts perforin, grB,
IFN-c and TNF-a were compared to the intra-TG HSV-1 and
VZV burden (Fig. 1E and F). A weak correlation was observed
between both perforin (p=0.04) and grB (p=0.004) mRNA
levels and the intra-TG HSV-1 DNA load, but not with the
latent VZV burden (Figure 1D and 1E). Furthermore, the
perforin (p,0.0001), grB (p,0.0001), IFN-c (p,0.0001) and
TNF-a mRNA levels (p=0.003) correlated strongly with CD8b
mRNA levels (Figure 1F) [5]. The data suggest that the extent of
CD8 T-cell infiltration in human TG is not only specifically
correlated with the latent HSV-1 burden, but is also transcrip-
tionally active to orchestrate an anti-viral function in situ. Finally,
the mRNA levels of CD8b (p=0.003), perforin (p=0.04), grB
(p=0.01), IFN-c (p,0.0001) and TNF-a (p,0.0005) correlated
strongly between the paired left and right TG indicating that the
intra-TG T-cell responses are symmetric intra-individually
(Figure 1G) [15].
Neuron-Interacting T-Cells in HSV-1 Latently Infected
Human TG Express Markers Congruent with T-Cells
Recognizing Antigen In Situ
Compared to HSV-1 negative human TG (Figure S1A), HSV-
1 DNA positive human TG are more densely infiltrated with T-
cells (Figures S1B), express significantly higher CD8b mRNA
levels (Figure S1C) and contain T-cells that on occasion cluster
near sensory neuron cell bodies (Figure 2A) [7,13,15]. Studies on
HSV-1 latently infected sensory ganglia in humans, and
particularly in experimentally infected mice, suggest the active
role of neuron-interacting T-cells to control neuronal HSV-1
latency [5,7,12–17]. We first analyzed the presence of TG-
infiltrating CD4 and CD8 T-cells by flow cytometry on single cell
suspensions of 15 TG of 8 HSV-1 IgG seropositive donors. The
data demonstrated infiltration of equivalent numbers of CD4 and
CD8 T-cells, with a median ratio of CD4 and CD8 T-cells of
0.99 (range 0.01 to 9.32), which also correlated between the
paired left and right TG (p,0.0002). Analogous flow cytometric
analysis of a TG of one HSV-1 seronegative donor demonstrated
a CD4/CD8 T-cell ratio of 1.1, which resembled that of the
HSV-1 seropositive donors. However, the limited number of
HSV-1 seronegative donors subjected to ex vivo flow cytometry
analyses withhold conclusions to be drawn on the virus-specific
Author Summary
HSV-1 is an endemic human herpesvirus worldwide that
establishes a lifelong latent infection of neurons in the
trigeminal ganglion (TG), allowing intermittent reactivation
resulting in recurrent disease in some persons. Studies in
HSV-1 models suggest a central role of TG-infiltrating virus-
specific CD8 T-cells to control reactivation. In humans,
however, the functional properties and fine specificity of
intra-TG T-cell responses remain enigmatic. The current
study used molecular, immunological and in situ analysis
platforms on human cadaveric TG obtained within hours
after death to characterize the local HSV-1 specific T-cell
response in latently infected human TG in detail. We
identified that CD4 and CD8 T-cells were juxtaposed to TG
neurons and expressed host transcripts and proteins
consistent with in situ antigen recognition and antiviral
function. The intra-TG T-cell response, involving both CD4
and CD8 T-cells, was directed to a limited set of HSV-1
proteins per person, which was not limited to a specific
kinetic or structural class of viral proteins. Collectively, the
data indicate that the human TG is an immunocompetent
environment for CD4 and CD8 T-cell recognition of diverse
HSV-1 proteins expressed during latent infection and that
the viral antigens identified herein are rational candidates
for HSV-1 subunit vaccines.
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role of retention of either T-cell subtype in human alphaherpes-
virus latently infected TG.
Subsequently, we aimed to corroborate the potential protective
role of neuron-interacting T-cell clusters by performing detailed in
situ analyses on HSV-1 latently infected human TG. Neuron-
interacting T-cell clusters consisted of both CD4 and CD8 T-cells
(Figure 2B). CD8 T-cells expressed both grB and the T-cell
intercellular antigen-1 (TIA-1) consistent with their cytotoxic
potential (Fig. 2B) [5,15]. We have recently shown that CD137, a
TNF receptor family member [26], is induced on HSV-1 reactive
human CD4 and CD8 T-cells shortly after recognition of HSV in
vitro [27,28]. Here, we demonstrated that neuron-interacting T-
cells in HSV-1 latently infected human TG express CD137 in situ,
implying that they have encountered their cognate antigen locally
(Fig. 2B).
Human TG-Derived HSV-1-Specific CD8 T-Cells Are
Directed to Viral Proteins across All Kinetic and
Functional Classes of Viral Proteins
To identify the viral proteins recognized by human TG
residing T-cells, T-cell lines (TCL) were generated by mitogenic
stimulation of TG-derived T-cells from twelve HSV-1 IgG
seropositive donors. The HSV-1–specific T-cells were pheno-
typed and enumerated by a flow cytometric intra-cellular IFN-c
(IFN-c ICC) assay using mock– and HSV-1–infected autologous
Epstein-Barr virus transformed B-cell lines (BLCL) as antigen-
Figure 1. Comparison of T-cell cytolytic granule and cytokine transcripts to HSV-1 and VZV DNA load, and CD8b transcript levels, in
human TG. (A) Scatter plot showing the mean HSV-1 and VZV genome equivalent copies (gec) per 105 TG cells. (B) Comparison of HSV-1 and VZV
DNA load in TG of individual donors. (C) Comparison between relative CD8b transcript levels and HSV-1 and VZV DNA load. (D) Comparison of HSV-1
DNA load with relative transcript levels of perforin, granzyme B (grB), interferon c (IFN-c) and tumor necrosis factor a (TNF-a). (E) Comparison of VZV
DNA load with relative transcript levels of perforin, grB, IFN-c and TNF-a. (F) Comparison between relative CD8b transcript levels and perforin,
granzyme B, IFN-c and TNF-a. (G) Comparison of the transcript levels of CD8b, perforin, grB, IFN-c and TNF-a between paired left and right TG of
individual donors. The paired T-test (A), Spearman correlation (B–F) and Wilcoxon matched pairs test (G) were used for statistical analysis. Data of 26
TG specimens analyzed.
doi:10.1371/journal.ppat.1003547.g001
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presenting cells (APC). The median percentage of HSV-1–
specific CD8 T-cells in the TG-TCL was 10% (range 2 to 37%)
and 4 of 12 TG-TCL also contained HSV-1-specific CD4 T-cells
(range 0.3 to 10%) (Table 1).
The HSV-1 proteins recognized by human TG-derived CD8
T-cells were determined using transfected Cos-7 cells as artificial
APC that expressed one of the donor’s HLA-A and –B alleles in
combination with 74 separate HSV-1 open reading frames
(ORFs) [27]. First, we used a set of partially HLA–A or –B allele
matched HSV-1-infected BLCL as APC to uncover both the
diversity and identity of HSV-1 peptide-presenting HLA class I
(HLA-I) alleles used by the CD8 T-cells. The data demonstrated
that the virus-specific intra-TG CD8 T-cell response is mediated
by 1 to 4 different HLA–A and –B alleles per person (Table 1).
Next, we used the implicated HLA-A and -B allele in HSV-1
ORFeome-wide screen [27]. We observed definitive HSV-1
ORFeome screen hits only when the net proportion of CD8 T-
cells reactive with HLA-matched HSV-1-infected BLCL was
.4% (data not shown). For some donors, we enriched and
expanded the TG-TCL using CD137 selection [27,28]. For this,
TG-TCL were incubated with HSV-1–infected autologous BLCL
and CD137+ CD8 T-cells were selected after 18 hours of
incubation and expanded with a T-cell mitogen to generate a
second generation TG-TCL. This led to an approximately 3-fold
enrichment of HSV-1 reactive CD8 T-cells for donors TG1, TG4
and TG12. The TG-TCL of donors TG8, TG9 and TG11
yielded insufficient enrichment or ample T-cell numbers to
perform HSV-1 ORFeome screens (data not shown).
In total, 8 of 12 HSV-1 reactive TG-TCL revealed reproducible
specific HSV-1 CD8 T-cell antigen hits (Figure 3). Thirteen
Figure 2. Localization and phenotype of T-cells in HSV-1 latently infected human TG. (A) Representative image of an HSV-1 latently
infected TG stained by immunohistochemistry (IHC) for CD3 (red). Inset: magnification of the TG tissue showing a cluster of CD3+ cells in panel A. (B;
left panel) Double immunofluoresence staining for CD4 (red) and CD8 (green) combined with DNA counterstaining (DAPI; blue nuclei). The white
arrows signify autofluorescent cytoplasmatic granules in neurons containing lipofuscin and neuron outlines are marked with white dotted lines. (B;
right panel) Consecutive TG tissue sections stained for CD8 (brown) and granzyme B (brown), CD8 (brown) and TIA-1 (brown), and CD3 (red) and
CD137 (red). Sections were developed with diaminobenzidine (brown staining pattern) or 3-amino-9-ethylcarbazole (red staining pattern) and
counterstained with hematoxylin (blue nuclei). Magnifications were: (A) 620 and inset 6200, (B; left panel) 6400 and (B; right panel) 61000.
Representative images from 10 HSV-1 latently infected TG donors analyzed.
doi:10.1371/journal.ppat.1003547.g002
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different CD8 T-cell viral targets were identified with 1 to 3 viral
proteins per TG-TCL (Figure 3). Virion protein 16 (VP16) and
particularly ICP6 were recognized by multiple TG-TCL in the
context of diverse HLA-A and –B alleles. In case of ICP6, 4 of 8
TG-TCL were positive and the protein was recognized via HLA-
A*3101 (donor TG7), –B*1501 (donor TG2) and in 3 different TG
donors via HLA-B*4001 (donors TG5, TG7 and TG12) (Figure 3).
Finally, candidate CD8 T-cell epitopes within several HSV-1
screen hit proteins were predicted by in silico algorithms [29].
Epitopes were subsequently validated by IFN-c ICC using
corresponding synthetic peptides and HLA-matched BLCL as
APC (Figures S2 and S3 and Table 2).
We recently studied antigenic targets of blood-derived HSV-1
specific CD8 T-cells in HSV-1 IgG seropositive healthy subjects
using related methodologies [27]. Systemic HLA–A and –B
restricted CD8 T-cell responses were directed to 14 HSV-1 ORFs
on average per person and 45 HLA–A and –B allele restricted
HSV-1 epitopes were identified [27]. To discern potential
similarities between systemic and intra-TG HSV-1 peptide
specific CD8 T-cell responses we tested TG-TCL of seven
HLA-A and -B allele matched TG donors for responses to the
HLA-appropriate HSV-1 peptides from our previous work on
blood-derived T-cells [27] (Table S1). Peptide-specific CD8 T-
cell responses were detected in two TG-TCL. The TG-TCL of
donor TG3 recognized four HLA-A*0101–restricted peptides:
gL66–74, gK201–209, and two VP16 peptides VP1690–99 and
VP16479–488. The HLA-A*2902–restricted VP13/14508–516 pep-
tide was recognized by the TG-TCL of donor TG6 (Table 2 and
Table S1) [27].
Collectively, the data demonstrated that human intra-TG HSV-
1–specific CD8 T-cell responses were directed to a relatively
restricted number of viral proteins per person. However, even
within the small population studied, we detected CD8 T-cell
responses to HSV-1 proteins in diverse kinetic and structural
classes (Table S2). Notably, the HSV-1 b protein ICP6 was a
prominent CD8 T-cell target in TG-TCL of 4 of 8 HLA-
discordant TG donors involving 3 different HLA-I alleles.
HSV-1-Specific Human TG-Derived CD4 T-Cells Recognize
Immediate Early and Late Viral Proteins
The intra-TG CD4 T-cell responses were analyzed in detail for
donors TG2 and TG3 (Table 1) [28]. CD4 T-cells of donor TG2
responded to the HSV-1 a protein ICP47 and subsequent assays
using whole ICP47-spanning peptides defined the antigenic region
at residues 57–75 (Figure 4A and 4B). For donor TG3, CD4 T-cell
reactivity was directed to the HSV-1 c1 protein VP16 (Figure 4A).
Application of truncated recombinant VP16 proteins and subse-
quently overlapping peptides identified two distinct antigenic
regions located between residues 187–203 and 215–238
(Figure 4C). Besides being a structural viral protein, VP16 has
also been implicated as a master initiator protein for HSV-1
neuronal reactivation in mice [30].
HSV-1 Epitope Specific CD8 T-Cells Localize in Close
Proximity to Sensory Neuron Cell Bodies in Human TG
The symmetry of the virus and T-cell parameters between
paired TG (Figure 1) [15], facilitated studies on the spatial
orientation of HSV-1 reactive CD8 T-cells in the contralateral
snap-frozen TG specimen of the same donor by in situ tetramer
staining (Figure 5) [31]. HSV-1 CD8 T-cell epitopes and
corresponding snap-frozen contralateral TG specimens were
available for donors TG2 and TG3. HLA-A*0201 tetramers
conjugated with identified ICP0642–651 and ICP81096–1105 epitopes
and HLA-A*0101 reagents with gL66–74, gK201–209, VP1690–99
and VP16479–488 epitopes (Table 2), were validated on the
corresponding TG-TCL (Figures S2 and S3). Whereas control
TG of HLA-A mismatched HSV-1 seropositive donors did not
reveal tetramer-positive CD8 T-cells (data not shown), HSV-1
Table 1. Phenotype and HLA class I allele restriction of HSV-1 reactive T-cells recovered from human TG.
TG donor HLA class I genotype Percentage HSV-1 reactive T-cells
Donor HLA-A HLA-B ratio CD4 CD8 HLA-A HLA-B
ID allele 1; 2 allele 1; 2 CD4/CD8# T-cells* T-cells* allele 1;2
$
allele 1;2
$
TG1 A*0201; A*1101 B*0702; B*4402 0.7 nd 5 4; 0 1; 0
TG2 A*0201 B*1501; B*4402 0.8 5 18 5 13; 0
TG3 A*0101 B*0801 5.4 0.3 11 11 0
TG4 A*0201; A*0301 B*3501; B*4402 nd 0 2 2; 0 0; 0
TG5 A*0301; A*3004 B*3501; B*4001 0.2 0 7 0; nd 0; 7
TG6 A*0301; A*2902 B*0702; B*4403 0.2 10 22 2; 1 19; 0
TG7 A*0301; A*3101 B*4001; B*5101 0.5 0 37 10; 9 18; 0
TG8 A*0101; A*02 B*07; B*0801 21.2 0 10 2; 3 5; nd
TG9 A*0201; A*6802 B*1402; B*5701 0.8 nd 5 1; 1 3; 0
TG10 A*0201; A*0301 B*3501 14.7 0 24 2; 22 0
TG11 A*0101; A*2902 B*0801; B*4403 2.9 nd 11.5 3; 2 3; 3.5
TG12 A*1101; A*3101 B*4001 0.7 4 10 3; 0 7
*TG-derived T-cell lines were incubated with mock– and HSV-1–infected autologous B-cell lines and assayed by flow cytometry for intra-cellular interferon gamma (IFN-
c) expression.
#The ratio of CD4 and CD8 T-cells of the respective TG-derived T-cell lines are indicated.
$
Patient HLA class I allele restricted HSV-1 reactive CD8 T-cell responses were defined using partially HLA class I matched BLCL. The values represent mean net
percentages of live/CD3-gated IFN-c+ T-cells (HSV-1 minus mock) of at least 2 separate experiments.
nd, not done.
doi:10.1371/journal.ppat.1003547.t001
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tetramer-positive CD8 T-cells were found juxtaposed to neuronal
cell bodies in TG of the respective donor (Figures 5 and S4, and
Movie S1).
Discussion
The host-pathogen standoff in human latent HSV-1 infection
permits periodic epithelial shedding of infectious virus, and
potential transmission, without overt host damage. In contrast,
HSV-1 mouse models are either acutely fatal or demonstrate tight
neuronal latency in which neither spontaneous nor stress-induced
ganglionic reactivation leads to peripheral release of infectious
virus [17,20,32]. In the current study, we demonstrated that the
human TG is an immunocompetent organ capable of presenting
viral antigens to both CD4 and CD8 T-cells, presumably over long
periods of time, to maintain local enrichment of HSV-1–specific
T-cells. The data imply that the HSV-1 proteins expressed in
latently infected human TG are not limited to a specific class of
kinetic or structural viral proteins and that the viral antigens
identified herein are rational candidates for HSV-1 subunit
vaccines.
In contrast to viral DNA and transcripts, viral proteins have not
been detected in HSV-1 latently infected human ganglia [5,7,13].
Viral protein synthesis may be shutdown or occur at low levels or
Figure 3. HSV-1 antigens recognized by human TG-derived CD8 T-cells. Representative data from TG-TCL of 6 TG donors assayed for T-cell
reactivity to proteins encoded by individual HSV-1 open reading frames (ORFs). Mean IFN-c secretion levels, shown as arbitrary OD450 values, by TG-
TCL exposed in duplicate to Cos-7 cells that co-express the respective donor-specific HLA class I allele and the individual HSV-1 ORFs arrayed in
nominal genomic order on the x-axis. The names of the HSV-1 ORFs and corresponding proteins specifically recognized are indicated by an arrow.
The HSV-1 ORFs recognized by the TG-TCL of donors TG2 and TG7 are shown in colors of the respective TG donor-specific HLA class I allele. ICP,
infected cell polypeptide; VP, virion protein and in case of a viral glycoprotein (e.g. gB, glycoprotein B). Currently, no proteins names are available for
HSV-1 ORFs UL6 and UL25.
doi:10.1371/journal.ppat.1003547.g003
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at low frequency. T-cells are activated by only a few MHC/
peptide-complexes making them highly sensitive and specific
biosensors to detect extremely low-level expression of their cognate
antigens [33]. The recognition of diverse HSV-1 proteins by
human TG infiltrating T-cells implies their cognate antigen
expression in situ. Moreover, the HSV-1 targets identified did not
group to a specific kinetic or functional class of viral proteins
suggesting that HSV-1 protein synthesis is not limited to early viral
proteins in latently infected human TG [5,7]. Alternatively, the T-
cell response reported herein may be directed to local reactivating
HSV-1, which has overcome cellular and viral control including
HSV-1 micro RNAs [6,7]. In contrast to humans, HSV-1 mouse
models are either fatal or have tight neuronal latency in which
spontaneous reactivation does not lead to peripheral release of
infectious virus [20,21]. Nevertheless, latently infected TG of
C57BL/6 mice contain neuron-interacting CD8 T-cells, directed
to 11 viral proteins including late structural HSV-1 proteins like
gC and gK [12,18,19]. These data imply that full HSV-1
reactivation is not a prerequisite to retain virus-specific T-cells in
ganglia with diverse viral protein reactivity. The combined human
and mouse data argue that this process involves recognition of the
T-cells’ cognate viral antigens produced locally in HSV-1 latently
infected ganglia [5,15,18,20].
Activation of HSV-1-specific CD8 T-cells in latently infected
murine ganglia is dependent on local CD4 T-cells, MHC class II
expression and recruited blood-derived APC [14,34]. The
current study documents inclusion of CD4 T-cells in neuron-
interacting T-cell clusters and proves peptide-level recognition of
HSV-1 by TG-resident CD4 T-cells in the natural host.
Intriguingly, VP16 was targeted by both CD8 and CD4 T-cells
in the same TG specimen (i.e., TG3) indicating local expression
and presentation of this viral protein by TG cells in the context of
both HLA-I and HLA-II molecules. Although local human APC
driving the HSV-1-specific CD4 T-cell responses could be blood-
derived or ganglion-resident [14,34], it is unlikely that HLA class
II negative neurons are directly involved. The data suggest of
HSV-1 proteins or remnants thereof from neurons to secondary
APC. We have recently shown that satellite glial cells (SGC),
which tightly envelop neuronal cell bodies in ganglia, are most
likely of myeloid origin [35]. Human TG-resident SGC are
related to macrophages and myeloid dendritic cells with regards
to their phagocytic capacity and expression of CD45, co-
stimulatory and HLA class II molecules [23]. Given their
localization and phenotype, SGC are candidate APC to create
an immunocompetent but not overtly inflammatory environment
to support HSV-specific CD4 and CD8 T-cell responses within
latently infected human TG.
An important and still unanswered question is the functional
role of the HSV-specific T-cells documented in this report. In the
absence of tools to selectively interrupt or bolster T-cells at specific
anatomic sites in humans, this question is difficult to address.
Surrogate data can be obtained by examining the phenotype and
activation status of human TG-resident CD8 T-cells. Integrating
human TG ex vivo flow cytometry and in situ data, it is evident that
TG-resident CD8 T-cells express CD137 and grB, and low levels
of CD27 and CD28, indicative of recent antigen encounter locally
[5,12,14,15,36]. Messenger RNA expression of the T-cell cytolytic
molecules perforin and grB directly correlated with HSV-1 DNA
levels (Figure 1D) and grB and TIA-1 protein expression co-
localized with neuron-surrounding CD8 T-cells (Figure 2B). The
fact that human TG-resident HSV-1-specific CD8 T-cells can
massively expand in vitro and then display brisk virus-specific IFN-c
responses argues against an exhausted phenotype [15,37]. Taken
together with the remarkable localization of HSV-1-specific CD8
T-cells juxtaposed to TG neurons (Figures 5 and S4 and Movie
S1), our data argue for a functional role for these cells in non-lytic
control of HSV-1 infection in human TG in cooperation with local
CD4 T-cells.
Table 2. HSV-1 antigens and epitopes recognized by CD8 T-cells recovered from human TG.
Kinetic class of the HSV-1 proteins recognized*
Donor ID HLA allele# Immediate early Early Late
TG1 A*0201 na na UL6 protein
TG1 A*0201 na na gB
TG2 A*0201 ICP0 (aa 642–651) ICP8 (aa1096–1105) na
TG2 B*1501 na ICP6 na
TG3 A*0101 na na gL (aa 66–74)
TG3 A*0101 na na gK (aa 201–209)
TG3 A*0101 na na VP16 (aa 90–99)
TG3 A*0101 na na VP16 (aa 479–488)
TG4 A*0201 na na UL25 protein
TG5 B*4001 na ICP6 na
TG6 A*2902 na na VP13/14 (aa 508–516)
TG6 B*0702 na Thymidine kinase VP11/12 (aa 386–394)
TG7 A*0301 ICP4 (aa 1096–1105) na na
TG7 A*3101 na ICP6 na
TG7 B*4001 na ICP6 VP16 (aa 163–175)
TG12 B*4001 na ICP6 na
*HSV-1 gene and protein names, and expression kinetic class, are from reference 1 and Genbank NC_001806. The amino acid (aa) location of CD8 T-cell epitopes
identified are in parentheses. na, not applicable.
#HLA allele by which the indicated proteins and peptides are recognized by the specific CD8 T-cells.
doi:10.1371/journal.ppat.1003547.t002
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If this interpretation is correct, elicitation of T-cells with anti-
viral activity in the latently infected TG is a rational goal for
preventative and therapeutic HSV-1 vaccines. Our findings have
several implications for HSV-1 vaccine design. First, ICP6 was
recognized by 4 of 8 TG donors in diverse HLA-I contexts
(Table 2). ICP6 is a ribonucleotide reductase subunit expressed
prior to viral DNA replication [1]. Because ICP6 was also a
dominant target for the systemic CD8 T-cell response in HSV-1
seropositive subjects [27], this protein is an attractive vaccine
candidate. Second, HSV-1 proteins of diverse kinetic and
structural classes were recognized by TG CD8 T-cells (Table 2).
These range from nonstructural a (ICP0 and ICP4) and b proteins
(ICP6 and thymidine kinase) to the late structural tegument
(VP11/12 and VP13/14) and envelope glycoproteins (gB, gK and
gL). Tegument protein VP16, recognized by both CD4 and CD8
TG-resident T-cells, is possibly a chameleon with both a hyper-
early role in neuronal reactivation and a structural role in
tegument assembly [30]. The cell biology implication of this
finding appears that diverse HSV-1 proteins are diverted from
viral assembly and access the HLA class I pathway in neurons, or
possibly surrounding APC after handover. Third, the apparent
diversity of recognized HSV-1 antigens is lower in TG than in
blood, where we detected a mean of 14 reactive HSV-1 ORFs per
person using similar technology [27]. The restricted clonality of
the human intra-TG T-cell response is consistent with T-cell
receptor spectratyping [5,15,36]. Surveys of more participants,
ideally with parallel studies on blood-derived T-cells, are
mandatory to determine if the breadth or fine specificity of the
paired TG and systemic HSV-1 T-cell responses differ and to pick
the best antigens for possible subunit approaches that target
sensory ganglia as a site of viral control. Manipulation of T-cell
priming or boosting to imprint a TG-homing program via
vaccination, without imparting an overly aggressive phenotype,
is an equally important and challenging task that must be
overcome to target the TG as an immunocompetent site for the
purpose of HSV-1 latency control.
Materials and Methods
Ethics Statement
Heparinized peripheral blood and paired TG specimens were
obtained from 39 individuals (median age 71 yrs, range 49–98 yrs)
at autopsy with a median post-mortem interval of 6.3 hrs (range
2.3–11.3 hrs). Specimens were collected by the Netherlands Brain
Bank (Netherlands Institute for Neuroscience; Amsterdam, the
Netherlands) from donors from whom a written informed consent
for brain autopsy and the use of the material and clinical
information for research purposes had been obtained. All study
Figure 4. HSV-1 antigens recognized by human TG-derived CD4 T-cells. (A) Representative data from the TG-TCL of the donors TG2 and TG3
assayed for T-cell reactivity by a proliferation assay to proteins encoded by individual HSV-1 open reading frames (ORFs). Cell lysates of mock- and
HSV-1 infected Cos-7 cells were used as negative and positive controls, respectively. Mean [3H]-thymidine incorporation by TG-TCL exposed in
duplicate to c-irradiated donor HLA-DQ/DR-matched allogeneic peripheral blood mononuclear cells (PBMC) pulsed with lysates generated from Cos-7
cells transfected with the individual HSV-1 ORFs arrayed in nominal genomic order on the x-axis. The names of the HSV-1 ORFs and corresponding
proteins driving the positive responses are indicated by an arrow. ICP47, infected cell polypeptide 47 and VP16, virus protein 16. (B) Proliferation
assay data of the TG-TCL of donor TG2 with c-irradiated HLA-DQ/DR TG 2-matched allogeneic PBMC pulsed with whole HSV-1 ICP47 protein (gene
US12) spanning synthetic peptides (15-meric peptides with 10 amino acid (aa) overlap) as antigen presenting cell (APC). (C; left panel) Proliferation
assay data of the TG-TCL of donor TG3 with c-irradiated HLA-DQ/DR-matched allogeneic PBMC pulsed with the indicated recombinant HSV-1 VP16
protein (gene UL48) fragments as APC. (C; right panel) Proliferation assay data of the TG-TCL of donor TG3 with c-irradiated HLA-DQ/DR-matched
allogeneic PBMC pulsed with HSV-1 VP16 protein fragment (aa151–240) spanning synthetic peptides (13-meric peptides with 8 aa overlap) as APC.
Data are presented as mean counts per minute of triplicate experiments. Data presented in (B) and (C) are the means 6 standard error of the mean.
doi:10.1371/journal.ppat.1003547.g004
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procedures were performed in compliance with relevant Dutch
laws and institutional guidelines, approved by the local ethical
committee (VU University Medical Center; Amsterdam, project
number 2009/148) and was performed in accordance with the
ethical standards of the Declaration of Helsinki. The majority of
the TG donors (n = 31) had a neurologic disease history affecting
the central nervous system (mainly Alzheimer’s and Parkinson’s
disease). Causes of death were not related to herpesvirus infections.
Blood was used to generate BLCL and for HLA typing as
described [15,27]. Plasma HSV-1 and VZV IgG levels were
determined by ELISA (Focus Diagnostics).
Generation and HSV-1-Specificity Testing of TG-Derived
TCL
TG-TCL were generated by phytohemagglutinin (PHA) stim-
ulation of TG cell suspensions, or of CD137-enriched TG-TCL,
using c-irradiated allogeneic PBMC and recombinant human IL-2
as described [15]. Antigen-specificity of TG-TCL was determined
by IFN-c ICC using the following APC: autologous or partially
HLA class I-matched BLCL infected overnight with HSV-1 with a
multiplicity of infection (MOI) of 10, or BLCL pulsed with 2 mM
of HSV-1 peptides [27]. Mock-infected BLCL were used as
negative controls. Cells were stained for CD4, CD8, CD3 and
IFN-c (all from Becton Dickinson; BD) and analyzed by multicolor
flow cytometry with Diva software (BD) as described [15]. Ex vivo
flow cytometry analyses for CD3, CD4, CD8 expression was
performed on single TG cell suspensions of a subset of 16 TG
specimens as described [15].
Isolation of Nucleic Acids and PCR Analysis of Human TG
Specimens
One-fifth of a dispersed TG cell suspension was used for RNA
and DNA isolation [15]. RNA was reverse transcribed using an
oligo-dT primer and used for quantitative real-time PCR (qPCR)
on an ABI Prism 7700 with Taqman Universal Master Mix and
commercial intron-spanning primer/probe-pairs specific for hu-
man perforin, grB, CD8b, TNF-a, IFN-c and b-actin (Applied
Biosystems) per manufacturer. The relative transcript levels were
determined by the formula 1,00062(2delCt), where delCt equals Ct
[(target gene) - Ct (b-actin)]. Intra-TG HSV-1 and VZV DNA
load were determined by qPCR as described [25].
CD137-Based Enrichment of Virus-Specific CD8 T-Cells
from TG-Derived TCL
To enrich HSV-1 reactive CD8 T-cells, autologous BLCL were
infected overnight with HSV-1 with a MOI of 10. TG-TCL were
added to the APC at a ratio of 1:1 for the next 24 hrs. Cells were
harvested, stained for CD3 (BD), CD8 (BD) and CD137
(Miltenyi). Cells that co-expressed CD3, CD8, and CD137 were
enriched with a BD FACS Aria cell sorter, expanded by PHA
stimulation and used in HSV-1 ORFeome screens as described
[27,28].
T-Cell Reactivity to HSV-1 ORFeome
The generation and validation of the HSV-1 ORFeome,
covering a total of 74 HSV-1 ORFs, for functional T-cell assays
has been detailed elsewhere [27]. In short, each HSV-1 ORF was
amplified and cloned into a custom-made eukaryotic expression
vector fused to the gene encoding enhanced green fluorescent
protein (eGFP). Donor-matched HLA-I specific cDNA (in
pcDNA3) and HSV-1 ORFs were expressed in Cos-7 cells (ATCC
CRL-1651) by transfection [27]. All HSV-1 ORFs were
transfected in duplicate and appropriate mock- or HSV-1 infection
controls were included. After 48 hrs, ORF expression was
confirmed by eGFP fluorescence and TG-TCL (56104/well) were
added to 104 transfected Cos-7 cells/well. After 24 h, supernatants
were collected for IFN-c ELISA [27].
Whole HSV-1 ORFeome screens to identify CD4 T-cell target
antigens were performed in duplicate as described [28,38].
Gamma-irradiated HLA-DQ/DR-matched allogeneic PBMC
were pulsed overnight with predefined dilutions of protein lysates
of HSV-1 ORF-transfected Cos-7 cells, HSV-1 proteins made
with bacterial lysates or peptides at 2 mM [28,38]. Ultraviolet light
treated mock- and HSV-1-infected Vero cell lysates were used as
negative and positive controls, respectively. After 48 hrs, [3H]-
thymidine was added and cells harvested to measure [3H]-
thymidine incorporation as marker for T-cell proliferation [27,38].
In Situ Analyses of Human TG Specimens
In situ immunofluorescence was performed using allophycocya-
nin (APC)-labeled CD4 (clone RPA-T4; BD) and FITC-labeled
CD8 (1A5; Monosan) monocloncal antibodies (mAbs). The APC
signal was enhanced by the FASER system per manufacturer
(Miltenyi). Sections were post-fixed with 4% (w/v) formaldehyde,
counterstained for DNA with DAPI (Invitrogen) and mounted
with ProLong Gold Antifade Reagent (Invitrogen). For immuno-
histochemistry, paraffin sections and cryosections of human TG
were stained as described [35]. The mAbs used were directed to
CD8 (1A5; Monosan), grB (GrB-7; Dako), TIA-1 (2G9; Im-
munotech), CD3 (UCHT1; Dako) and CD137 (4B4-1; BD).
Sections were counterstained with hematoxylin and mounted with
glycerol gelatin. The ratio of CD3+ cells per neuron in TG of
Figure 5. HSV-1 epitope-specific CD8 T-cells are localized close
to sensory neuron cell bodies in the contralateral human TG.
Representative image of the TG tissue of donor TG2 stained with DAPI
(blue), anti-CD8 (green) and tetramers (red) that consisted of both the
synthetic HSV-1 peptides ICP0642–651 and ICP81096–1105 conjugated to
HLA-A*0201. Inserts, lower left and upper right corner, are enlarge-
ments of areas containing tetramer-positive CD8 T-cells. The white
arrows and arrowheads signify autofluorescent granules containing
lipofuscin and tetramer-positive CD8 T-cells, respectively. Neuron
outlines are marked with a white dashed line. Magnification was6400.
doi:10.1371/journal.ppat.1003547.g005
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HSV-1 serotyped donors was determined by counting all sensory
neuronal cell bodies and CD3+ cells in multiple sections (n = 3–5),
cut at different anatomic levels of the same TG specimen, under
the microscope as described previously [39]. The average number
CD3+ cells/neuron per TG are presented.
In situ tetramer stainings were performed as described previously
[31]. In brief, TG cryosections (8 mm) were fixed with 4% (w/v)
formaldehyde and incubated with 2–4 mg of the respective APC-
conjugated HSV-1 peptide/HLA-I tetramers at 4uC for 20 hrs.
Next, slides were washed and post-fixed in 4% formaldehyde.
Slides were counterstained with anti-CD8 (3B5; Invitrogen) and
DAPI (Invitrogen), and mounted with ProLong Gold Antifade
Reagent (Invitrogen). Fluorescent images were acquired on a Zeiss
LSM700 confocal laser scanning microscope.
Statistical Analysis
Statistical differences between were determined by the Mann-
Whitney test, paired T-test, Spearman correlation test and
Wilcoxon matched-pairs signed-rank test. P,0.05 were considered
significant.
Supporting Information
Figure S1 T-cell retention in human TG correlates with
HSV-1 latency. (A) Representative image of a HSV-1 negative
human TG stained by immunohisto-chemistry for CD3 (red).
Sections were developed with 3-amino-9-ethylcarbazole (red
staining pattern) and counterstained with hematoxylin (blue
nuclei). Magnification was 620. Note the limited number of
infiltrating CD3+ cells that, in contrast to a TG of a representative
HSV-1 positive donor (see Fig. 2A), did not form neuron-
interacting T-cell clusters. Representative image from 5 HSV-1
negative TG donors analyzed. (B) Scatter plot showing the mean
number of CD3+ cells per neuronal cell body in TG of HSV-1
seropositive (n = 7) and seronegative (n = 3) individuals. (C) Scatter
plot showing the mean relative CD8b transcript levels in human
TG that are HSV-1 DNA positive (n = 17) or negative (n = 9). (B
and C) The Mann-Whitney test was used for statistical analysis.
(TIFF)
Figure S2 Validation of HSV-1 peptide-specific tetra-
mers on the TG-TCL of donor TG2. The TG-TCL of donor
TG2 were incubated with mock- and -HSV-1 infected, and
peptide-pulsed, autologous B-cell lines for 16 hrs. Gated live and
CD3+ cells were assayed by flow cytometry for intra-cellular
gamma interferon (IFN-c), and surface CD3 and CD8 expression.
Additionally, the donor’s TG-TCL, or a relevant HLA-A allele
mismatched TG-TCL, were incubated with the corresponding
fluorochrome-conjugated HLA class I tetramers for 1 hr and
binding determined on live gated cells in combination with CD3
and CD8 staining (lower row). Numbers are percentages of cells in
the upper right quadrant. aa, amino acid; ICP, infected cell
polypeptide.
(TIF)
Figure S3 Validation of HSV-1 peptide-specific tetra-
mers on the TG-TCL of donor TG3. The TG-TCL of donor
TG3 were incubated with mock- and -HSV-1 infected, and
peptide-pulsed, autologous B-cell lines for 16 hrs. Gated live and
CD3+ cells assayed by flow cytometry for intra-cellular gamma
interferon (IFN-c), and surface CD3 and CD8 expression.
Additionally, the donor’s TG-TCL, or a HLA-A allele mis-
matched TG-TCL, were incubated with the corresponding
fluorochrome-conjugated HLA class I tetramers for 1 hr and
binding determined on live gated cells in combination with CD3
and CD8 staining (lower row). Numbers are percentages of cells in
the upper right quadrant. aa, amino acid; VP, virus protein; gK,
glycoprotein K and gL, glycoprotein L.
(TIFF)
Figure S4 HSV-1 epitope-specific CD8 T-cells are
localized in the vicinity to sensory neuron cell bodies
in human TG tissue. Representative optical sections from snap-
frozen TG tissue of donor TG3 stained with DAPI (blue), anti-
CD8 (green) and tetramers (red) that consisted of the synthetic
HSV-1 peptides gL66–74 (upper panel), VP1690–99 (middle panel)
and gK201–209 (lower panel) bound to HLA-A*0101. The white
arrows and arrow heads signify autofluorescent granules contain-
ing lipofuscin and tetramer-positive cells, respectively. Boxed areas
in the upper and middle panels are enlarged in the corresponding
images to the right. Note that for the HLA-A*0201/VP1690–99
tetramer staining anti-CD8 was omitted. Neuron outlines are
marked with a white dashed line. Magnifications were6400 and
in the insets6800.
(TIFF)
Movie S1 Three-dimensional reconstruction of optically
sectioned snap-frozen TG tissue of donor TG2 stained
with DAPI (blue), anti-CD8 (green) and tetramers (red)
that consisted of both the synthetic HSV-1 peptides
ICP0642–651 and ICP81096–1105 conjugated to HLA-A*0201.
Image stack size is 75 (x)675 (y)68 (z) mm.
(MOV)
Table S1 HSV-1 peptide responses in TG-TCL of HLA
class I concordant TG donors. TG-derived T-cell lines (TG-
TCL) from the indicated TG donors were incubated with the
relevant HLA class I allele matched B-cell lines pulsed with the
indicated peptides and assayed by flow cytometry for intra-cellular
IFN-c expression. The values represent the mean net percentages
of live/CD3-gated IFN-c (i.e., peptide minus mock pulsed BLCL
used as antigen presenting cells) of at least 2 separate experiments.
(DOC)
Table S2 Characteristics of HSV-1 proteins recognized
by human TG-derived CD4 and CD8 T-cells. The
expression kinetics classification of the HSV-1 proteins recognized
by human TG-derived CD4 and CD8 T-cells are designated as a
(immediate early), b (early), c1 (late) and c2 (late late).
Furthermore, the classification of HSV-1 proteins that are essential
(E) or non-essential (nonE) for virus growth in cell culture are
provided.
(DOC)
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